Elanco Animal Health Inc — Income Charts
8 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+12.2% +$124M
$1.14B
Cost of Revenue↑+10.8% +$54M
$555M
Gross Profit↑+13.5% +$70M
$589M
R&D↑+14.8% +$12M
$93M
SG&A↑+12.7% +$38M
$338M
D&A↑+6.1% +$10M
$174M
EBITDA↑+6.1% +$10M
$174M
Interest Expense
$58M
Pretax Income↓-108.9% -$609M
$-50M
Tax Provision
$17M
Net Income↓-109.3% -$398M
$-34M
Gross Margin↑+0.6pts
51.5%
Net Margin↓-38.3pts
-3.0%
Effective Tax Rate↓-2.9pts
32.0%
Deferred Tax Liabilities
$15M
ETR (Continuing Operations)
-3.5%
ETR Federal Statutory
21.0%
ETR State + Local (pp)
-0.9%
Operating Lease Cost↑+30.0% +$9M
$39M
Pension Net Periodic Cost
—
Revenue YoY Variation↑+13.6pts
12.2%
Revenue QoQ Variation↑+1.6pts
0.6%